14d
Axios on MSNFunding for Moderna bird flu vaccine under reviewThe Trump administration confirmed it's reviewing whether to pull $590 million in funding that Moderna received in the final days of the Biden administration to develop an mRNA vaccine for bird flu in ...
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources.
American pharmaceutical company Moderna (MRNA) is reportedly under scrutiny by U.S. President Donald Trump’s team, which is considering ...
HHS review of a vaccine contract sparks worries about preparedness for a potential bird flu pandemic
HHS is re-evaluating a nearly $600 million contract with Moderna to develop and test vaccines against flu viruses that could ...
Sky-high egg prices have drawn renewed attention to the bird flu outbreak, which has caused more than 166 million wild and ...
Highly pathogenic avian influenza continues to devastate poultry flocks throughout the United States, as well as cause ...
The Biden and Trump administrations have put billions into bird flu monitoring and prevention. But where is that money going?
The CDC has sequenced bird flu viruses from people in Nevada and Wyoming, and the Trump Administration has released a ...
New infections in animals should heighten concern of human H5N1.
Arcturus Therapeutics believes it’s “highly unlikely” it will lose the promised government funding for its bird flu mRNA ...
A new avian flu vaccine, developed by New Jersey-based Zoetis, was approved last week after meeting safety and efficacy standards.
Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results